Butyrylcholinesterase in Guinea Pig Lung Lavage: A Novel Biomarker to Assess Lung Injury Following Inhalation Exposure to Nerve Agent VX

REFERENCES

• Abdel-Rahman A., Shetty A. K., Abou-Donia M. B. Acute exposure to sarin increases blood brain barrier permeability and induces neuropathological changes in the rat brain: Dose-response relationships. Neuroscience 2002; 113: 721–741, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Anthony J. S., Haley M., Manthei J., Way R., Burnett D., Gaviola B., Sommerville D., Crosier R., Mioduszewski R., Thomson S., Crouse C., Matson K. Inhalation toxicity of cyclosarin (GF) vapor in rats as a function of exposure concentration and duration: Potency comparison to sarin (GB). Inhal. Toxicol. 2004; 16: 103–111, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Ashani Y., Shapira S., Levy D., Wolfe A. D., Doctor B. P., Raveh L. Butyrylcholinesterase and acetylcholinesterase prophylaxis against soman poisoning in mice. Biochem. Pharmacol. 1991; 41: 37–41, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Bajgar J., Sevelova L., Krejcova G., Fusek J., Vachek J., Kassa J., Herink J., De Jong L. P., Benschop H. P. Biochemical and behavioral effects of soman vapors in low concentrations. Inhal. Toxicol. 2004a; 16: 497–507, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Bajgar J., Sevelova L., Krejcova G., Fusek J., Vachek J., Kassa J., Herink J., De Jong L. P., Benschop H. P. Biochemical and behavioral effects of soman vapors in low concentrations. Inhal. Toxicol. 2004b; 16: 497–507, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Benschop H. P., Trap H. C., Spruit H. E., van der Wiel H. J., Langenberg J. P., De Jong L. P. Low level nose-only exposure to the nerve agent soman: Toxicokinetics of soman stereoisomers and cholinesterase inhibition in atropinized guinea pigs. Toxicol. Appl. Pharmacol. 1998; 153: 179–185, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Bide R. W., Risk D. J. Inhalation toxicity in mice exposed to sarin (GB) for 20–720 min. J. Appl. Toxicol. 2004; 24: 459–467, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Buchanan K. C., Burge R. R., Ruble G. R. Evaluation of injectable anesthetics for major surgical procedures in guinea pigs. Contemp. Top. Lab. Anim. Sci. 1998; 37: 58–63, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Cohan S. L., Pohlmann J. L., Mikszewski J., O'Doherty D. S. The pharmacokinetics of pyridostigmine. Neurology 1976; 26: 536–539, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Damodaran T. V., Jones K. H., Patel A. G., Abou-Donia M. B. Sarin (nerve agent GB)-induced differential expression of mRNA coding for the acetylcholinesterase gene in the rat central nervous system. Biochem. Pharmacol. 2003; 65: 2041–2047, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• DeLorenzo R. A. Exposed. Signs, symptoms & EMS management of nerve-agent poisoning. J Emerg. Med. Serv. 2001; 26: 48–57, [CSA]
   PubMedGoogle Scholar
• Doctor B. P., Saxena A. Bioscavengers for the protection of humans against organophosphate toxicity. Chem. Biol. Interact. 2005; 157–158: 167–171, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Doctor B. P., Toker L., Roth E., Silman I. Microtiter assay for acetylcholinesterase. Anal. Biochem. 1987; 166: 399–403, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Doctor B. P., Raveh L., Wolfe A. D., Maxwell D. M., Ashani Y. Enzymes as pretreatment drugs for organophosphate toxicity. Neurosci. Biobehav. Rev. 1991; 15: 123–128, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Ellman G. L., Courtney K. D., Andres V., Jr., Feather-Stone R. M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961; 7: 88–95, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Feaster S. R., Quinn D. M. Mechanism-based inhibitors of mammalian cholesterol esterase. Methods Enzymol. 1997; 286: 231–252, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Feaster S. R., Lee K., Baker N., Hui D. Y., Quinn D. M. Molecular recognition by cholesterol esterase of active site ligands: Structure–reactivity effects for inhibition by aryl carbamates and subsequent carbamylenzyme turnover. Biochemistry 1996; 35: 16723–16734, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Gordon R. K., Feaster S. R., Russell A. J., LeJeune K. E., Maxwell D. M., Lenz D. E., Ross M., Doctor B. P. Organophosphate skin decontamination using immobilized enzymes. Chem. Biol. Interact. 1999; 119–120: 463–470, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Gordon R. K., Haigh J. R., Garcia G. E., Feaster S. R., Riel M. A., Lenz D. E., Aisen P. S., Doctor B. P. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman. Chem. Biol. Interact. 2005; 157–158: 239–246, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Jimmerson V. R., Shih T. M., Maxwell D. M., Kaminskis A., Mailman R. B. The effect of 2-(o-cresyl)-4H-1:3:2-benzodioxaphosphorin-2-oxide on tissue cholinesterase and carboxylesterase activities of the rat. Fundam. Appl. Toxicol. 1989; 13: 568–575, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Kadivar H., Adams S. C. Treatment of chemical and biological warfare injuries: Insights derived from the 1984 Iraqi attack on Majnoon Island. Mil. Med. 1991; 156: 171–177, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Karalliedde L., Gauci C. A., Carter M. Chemical weapons. Br. Med. J. 1991; 302: 474, [CSA]
   PubMed Web of Science ®Google Scholar
• Kropp T., Richardson R. Relative inhibitory potencies of chlorpyrifos oxon, chlorpyrifos methyl oxon, and mipafox for acetylcholinesterase versus neuropathy target esterase. J. Toxicol. Environ. Health A 2003; 66: 1145–1157, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Langenberg J. P., Spruit H. E., van der Wiel H. J., Trap H. C., Helmich R. B., Bergers W. W., van Helden H. P., Benschop H. P. Inhalation toxicokinetics of soman stereoisomers in the atropinized guinea pig with nose-only exposure to soman vapor. Toxicol. Appl. Pharmacol. 1998; 151: 79–87, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Logan T. P., Millard C. B., Shutz M., Schulz S. M., Lee R. B., Bongiovanni R. Cutaneous uptake of 14C-HD vapor by the hairless guinea pig. Drug Chem. Toxicol. 1999; 22: 375–387, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Magnotti R. A., Jr., Eberly J. P., Quarm D. E., McConnell R. S. Measurement of acetylcholinesterase in erythrocytes in the field. Clin. Chem. 1987; 33: 1731–1735, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Masuda N., Takatsu M., Morinari H., Ozawa T. Sarin poisoning in Tokyo subway. Lancet 1995; 345: 1446, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Maxwell D. M., Brecht K. M. Carboxylesterase: Specificity and spontaneous reactivation of an endogenous scavenger for organophosphorus compounds. J. Appl. Toxicol. 2001; 21(suppl 1)S103–S107, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Niven A. S., Roop S. A. Inhalational exposure to nerve agents. Respir. Care Clin. North Am. 2004; 10: 59–74, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Okumura T., Takasu N., Ishimatsu S., Miyanoki S., Mitsuhashi A., Kumada K., Tanaka K., Hinohara S. Report on 640 victims of the Tokyo subway sarin attack. Ann. Emerg. Med. 1996; 28: 129–135, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Racke K., Matthiesen S. The airway cholinergic system: Physiology and pharmacology. Pulmon. Pharmacol. Ther. 2004; 17: 181–198, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Raveh L., Ashani Y., Levy D., De La H. D., Wolfe A. D., Doctor B. P. Acetylcholinesterase prophylaxis against organophosphate poisoning. Quantitative correlation between protection and blood-enzyme level in mice. Biochem. Pharmacol. 1989; 38: 529–534, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Ray R., Clark O. E., III, Ford K. W., Knight K. R., Harris L. W., Broomfield C. A. A novel tertiary pyridostigmine derivative [3-(N, N-dimethylcarbamyloxy)-1-methyl-delta 3-tetrahydropyridine]: Anticholinesterase properties and efficacy against soman. Fundam. Appl. Toxicol. 1991; 16: 267–274, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Saxena A., Sun W., Luo C., Doctor B. P. Human serum butyrylcholinesterase: In vitro and in vivo stability, pharmacokinetics, and safety in mice. Chem. Biol. Interact. 2005; 157–158: 199–203, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Shih T. M., McDonough J. H., Jr. Organophosphorus nerve agents-induced seizures and efficacy of atropine sulfate as anticonvulsant treatment. Pharmacol. Biochem. Behav. 1999; 64: 147–153, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• van Helden H. P., Trap H. C., Kuijpers W. C., Oostdijk J. P., Benschop H. P., Langenberg J. P. Low-level exposure of guinea pigs and marmosets to sarin vapour in air: Lowest-observable-adverse-effect level (LOAEL) for miosis. J. Appl. Toxicol. 2004; 24: 59–68, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Wessler I. K., Kirkpatrick C. J. The non-neuronal cholinergic system: An emerging drug target in the airways. Pulmon. Pharmacol. Ther. 2001; 14: 423–434, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Wessler I., Kirkpatrick C. J., Racke K. Non-neuronal acetylcholine, a locally acting molecule, widely distributed in biological systems: Expression and function in humans. Pharmacol. Ther. 1998; 77: 59–79, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar